Fidelity Investments
ACER

Fidelity Investments’s Acer Therapeutics Inc ACER Stock Holding History

Fidelity Investments’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-381
Closed – – 5539
2022
Q2 		$0 Sell
381
-209
-35% -$438 ﹤0.01% 5642
2022
Q1 		$2K Buy
+590
New +$1.42K ﹤0.01% 4735
2020
Q3 		– Sell
-1
Closed – – 4087
2020
Q2 		$0 Buy
+1
New +$3 ﹤0.01% 4295

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CF
Copperwynd Financial Scottsdale, Arizona $401M AUM 20.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments's ACER Position: Q3 2022 in Review

Fidelity Investments sold out of Acer Therapeutics Inc (ACER) in Q3 2022, closing a stake of 381 shares.

Fidelity Investments first reported a position in ACER in Q2 2020 and held it in 3 quarters. The position peaked at $2K in Q1 2022. 28 funds tracked by Wall St. Rank hold ACER as of Q3 2022.

  • Fidelity Investments reported no remaining Acer Therapeutics Inc position as of Q3 2022 after selling out during the quarter.
  • Fidelity Investments sold 381 Acer Therapeutics Inc shares in Q3 2022.
  • Fidelity Investments first reported a position in Acer Therapeutics Inc in Q2 2020 and held it in 3 quarters.
  • Fidelity Investments's Acer Therapeutics Inc position peaked at $2K in Q1 2022.
  • 28 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2022.

Based on Fidelity Investments's 13F filing for Q3 2022, filed 10 Nov 2022.